Subacute inhalation toxicity study of synthetic amorphous silica nanoparticles in Sprague-Dawley rats

References

• Alexander DJ, Collins CJ, Coombs DW, et al. (2008). Association of Inhalation Toxicologists (AIT) working party recommendation for standard delivered dose calculation and expression in non-clinical aerosol inhalation toxicology studies with pharmaceuticals. Inhal Toxicol 20:1179–89.
   PubMed Web of Science ®Google Scholar
• Arts JH, Muijser H, Duistermaat E, et al. (2007). Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. Food Chem Toxicol 45:1856–67.
   PubMed Web of Science ®Google Scholar
• Barik TK, Sahu B, Swain V. (2008). Nanosilica-from medicine to pest control. Parasitol Res 103:253–8.
   PubMed Web of Science ®Google Scholar
• Card JW, Zeldin DC, Bonner JC, Nestmann ER. (2008). Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 295:L400–11.
   PubMed Web of Science ®Google Scholar
• Cheng SH, Lee CH, Chen MC, et al. (2010). Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics: the trio of imaging, targeting and therapy. J Mater Chem 20:6149–57.
   Web of Science ®Google Scholar
• Coccini T, Barni S, Vaccarone R, et al. (2013). Pulmonary toxicity of instilled cadmium-doped silica nanoparticles during acute and subacute stages in rats. Histol Histopathol 28:195–209.
   PubMed Web of Science ®Google Scholar
• Du Z, Zhao D, Jing L, et al. (2013). Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation. Cardiovasc Toxicol 13:194–207.
   PubMed Web of Science ®Google Scholar
• Fruijtier-Pölloth C. (2012). The toxicological mode of action and the safety of synthetic amorphous silica-a nanostructured material. Toxicology 294:61–79.
   PubMed Web of Science ®Google Scholar
• Giknis MA, Clifford CB. (2008). Clinical laboratory parameters for Crl: WI(Han). Wiilmington, MA: Charles river.
   Google Scholar
• Guichard Y, Maire MA, Sébillaud S, et al. (2015). Genotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 2: intratracheal instillation and intravenous injection. Environ Mol Mutagen 56:228–44.
   PubMed Web of Science ®Google Scholar
• Hemenway DR, Absher MP, Landesman M, et al. (1986). Differential lung response following silicon dioxide polymorph aerosol exposure. In: Goldsmith DF, Winn MD, Shy CM (eds.). Silica, silicosis and cancer. Controversy in occupational Medicine. Vol. 2, New York: Prager, 105–116.
   Google Scholar
• Hinds WC. (1999). Coagulation. In: Aerosol technology: properties, behavior, and measurement of airborne particles. 2nd ed. Hoboken, NJ: Wiley-Interscience.
   Google Scholar
• Holsapple MP, Farland WH, Landry TD, et al. (2005). Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs. Toxicol Sci 88:12–17.
   PubMed Web of Science ®Google Scholar
• IARC. (1997). IARC monographs on the evaluation of carcinogenic risks to humans, some silicates, cola dust and para-aramid fibrils. Vol. 68. Lyon, France: IRAC.
   Google Scholar
• IARC. (2012). IARC monographs on the evaluation of carcinogenic risks to humans: Arsenic, metals, fibres, and dusts. Vol. 110C. Lyon, France: IRAC
   Google Scholar
• Johnston CJ, Driscoll KE, Finkelstein JN, et al. (2000). Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol Sci 56:405–13.
   PubMed Web of Science ®Google Scholar
• Kaewamatawong T, Kawamura N, Okajima M, et al. (2005). Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol Pathol 33:743–9.
   PubMed Web of Science ®Google Scholar
• Karlsson HL, Gustafsson J, Cronholm P, Möller L. (2009). Size-dependent toxicity of metal oxide particles-a comparison between nano- and micrometer size. Toxicol Lett 188:112–18.
   PubMed Web of Science ®Google Scholar
• Lee KP, Kelly DP. (1992). The pulmonary response and clearance of Ludox colloidal silica after a 4-week inhalation exposure in rats. Fundam Appl Toxicol 19:399–410.
   PubMedGoogle Scholar
• Lee KP, Kelly DP. (1993). Translocation of particle-laden alveolar macrophages and intraalveolar granuloma formation in rats exposed to Ludox colloidal amorphous silica by inhalation. Toxicology 77:205–22.
   PubMed Web of Science ®Google Scholar
• Leung CC, Yu IT, Chen W. (2012). Silicosis. Lancet 379:2008–18.
   PubMed Web of Science ®Google Scholar
• Lin W, Huang YW, Zhou XD, Ma Y. (2006). In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217:252–9.
   PubMed Web of Science ®Google Scholar
• Liu T, Li L, Fu C, et al. (2012). Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. Biomaterials 33:2399–407.
   PubMed Web of Science ®Google Scholar
• MPPD v 2.11. (2002). Multiple-path particle Dosimetry. Model v.2.0. Arlington, VA.
   Google Scholar
• Napierska D, Thomassen LC, Lison D, et al. (2010). The nanosilica hazard: another variable entity. Part Fibre Toxicol 7:39.
   PubMed Web of Science ®Google Scholar
• National Institute of Occupational Safety and Health (NIOSH). (1994a) Manual of Analytical Method 0500: Particulate not otherwise regulated, Total.
   Google Scholar
• National Institute of Occupational Safety and Health (NIOSH). (1994b). Manual of Analytical Method 7402: Asbestos by TEM.
   Google Scholar
• Nel A, Xia T, Mädler L, Li N. (2006). Toxic potential of materials at the nanolevel. Science 311:622–7.
   PubMed Web of Science ®Google Scholar
• OECD. (2009). OECD guidelines for the testing of chemicals, Section 4/Test No. 412: subacute inhalation toxicity: 28-day study. Paris: OECD.
   Google Scholar
• Oh S, Kim B, Kim H. (2014). Comparison of nanoparticle exposures between fumed and sol-gel nano-silica manufacturing facilities. Ind Health 52:190–8.
   PubMed Web of Science ®Google Scholar
• Ostraat ML1, Swain KA, Krajewski JJ. (2008). SiO2 aerosol nanoparticle reactor for occupational health and safety studies. J Occup Environ Hyg 5:390–8.
   PubMed Web of Science ®Google Scholar
• Poland CA, Duffin R, Kinloch I, et al. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423–8.
   PubMed Web of Science ®Google Scholar
• Roelofs F, Vogelsberger W. (2004). Dissolution kinetics of synthetic amorphous silica in biological-like media and its theoretical description. J Phys Chem B 108:11308–16.
   Web of Science ®Google Scholar
• Ryman-Rasmussen JP, Cesta MF, Brody AR, et al. (2009). Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol 4:747–51.
   PubMed Web of Science ®Google Scholar
• Sayes CM, Reed KL, Glover KP, et al. (2008). Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles. Inhal Toxicol 22:348–54.
   Web of Science ®Google Scholar
• Stöber W, Fink A, Bohn E. (1968). Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 26:62–9.
   Web of Science ®Google Scholar
• Sutunkova MP, Solovyeva SN, katsnelson BA, et al. (2017). A paradoxical response of the rat organism to long-term inhalation of silica-containing submicron (predominantly nanoscale) particles of a collected industrial aerosol at realistic exposure levels. Toxicology 384:59–68.
   PubMed Web of Science ®Google Scholar
• Tsai CP, Chen CY, Hung Y, et al. (2009). Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem 19:5737–43.
   Web of Science ®Google Scholar
• Vogelsberger W, Schmidt J. (2009). Dissolution behavior of a nanoparticle in a microscale volume of solvent: thermodynamic and kinetic considerations. Inhal Toxicol 21:8–16.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao Q, Han N, et al. (2015). Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine 11:313–27.
   PubMed Web of Science ®Google Scholar
• Warheìt DB, McHugh TA, Hartsky MA. (1995). DifferentiaI pulmonary responses in rats inhaling crystalline, colloidal or amorphous silica dusts. Scand J Work Environ Health 21:19–21.
   PubMed Web of Science ®Google Scholar
• Whalan JE, Foureman GL, Vandenberg JJ. (2006). Inhalation risk assessment at the Environmental Protection Agency. In: Salem H, Katz SA (eds). Inhalation toxicology. 2nd edn. Boca Raton, FL: CRC Press, 26–8.
   Google Scholar
• Yazdi AS, Guarda G, Riteau N, et al. (2010). Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci USA 107:19449–54.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Yoshioka Y, Tochigi S, et al. (2013). Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice. Part Fibre Toxicol 10:41.
   PubMed Web of Science ®Google Scholar
• Yu Y, Li Y, Wang W, et al. (2013). Acute toxicity of amorphous silica nanoparticles in intravenously exposed ICR mice. PLoS One 8:e61346.
   PubMed Web of Science ®Google Scholar